Clinical Trials for Primary Peritoneal Carcinoma

Find clinical trials for primary peritoneal carcinoma. Discover research opportunities and treatment options in your area.

25 Active Trials Found

Showing 25 trials on this page

Page 1 of 2

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT ID: NCT05527184

This clinical trial, called IMGN151-1001, is testing a new treatment called IMGN151 for women with certain types of recurrent cancers, specifically endometrial cancer and high-grade ovarian, perito...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Los Angeles, California, United States +37 more

National Cancer Institute "Cancer Moonshot Biobank"

NCT ID: NCT04314401

The "Cancer Moonshot Biobank" is a clinical trial that aims to gather blood and tissue samples from patients diagnosed with various types of cancer, including advanced stages of breast cancer, lung...

Recruiting

Type: observational Locations: Des Moines, Iowa, United States, Scarborough, Maine, United States +176 more

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT ID: NCT06915025

This clinical trial is studying a new treatment called IMNN-001, which will be given directly into the abdomen along with standard chemotherapy for women who have been newly diagnosed with advanced...

Not yet recruiting

Phase: PHASE3 Type: interventional

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT ID: NCT05579366

This clinical trial is investigating a new drug called PRO1184 for patients with various types of advanced solid tumors, including different forms of ovarian, lung, and breast cancer. The main goal...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Providence, Rhode Island, United States +42 more

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

NCT ID: NCT05429970

The PRESERVE clinical trial is exploring whether a combination of medications, specifically propranolol and etodolac, along with mind-body resilience training and music therapy, can help reduce str...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +7 more

A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy

NCT ID: NCT05460000

This clinical trial is investigating a new treatment approach for women with advanced high-grade ovarian cancer and related conditions, specifically looking at the effectiveness of a medication cal...

Recruiting

Phase: PHASE2 Type: interventional Locations: Leipzig, , Germany, Valencia, , Spain +44 more

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

NCT ID: NCT06870539

This clinical trial is exploring a new way to monitor cytomegalovirus (CMV) infection using saliva samples from women undergoing treatment for ovarian cancer. CMV is a virus that can affect some ca...

Recruiting

Type: observational Locations: Minneapolis, Minnesota, United States, Rochester, Minnesota, United States

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

NCT ID: NCT03604315

This clinical trial is testing a new imaging technique using a special radioactive agent called Fluorine F 18 fluorthanatrace, or [^18F] FTT, to help doctors see solid tumors more clearly in women ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

NCT ID: NCT06469281

This clinical trial is studying a new treatment called 27T51, which is a type of immune cell therapy designed to help fight certain types of ovarian cancer, including epithelial ovarian cancer, pri...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Pittsburgh, Pennsylvania, United States +3 more

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

NCT ID: NCT00488878

This clinical trial is focused on gathering important information about patients who have low-grade ovarian or peritoneal tumors. These tumors are types of cancer that grow slowly and may not behav...

Recruiting

Type: observational Locations: Houston, Texas, United States

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

NCT ID: NCT05200260

This clinical trial is exploring the best timing for surgery combined with targeted therapy for women with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal carcinoma. The goal ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China, Foshan, , China +7 more

A Study of Sovilnesib in Subjects with Ovarian Cancer

NCT ID: NCT06084416

This clinical trial is studying a new medication called sovilnesib to see how safe it is and how well it works for women with advanced ovarian cancer, specifically a type called high-grade serous a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Birmingham, Alabama, United States, Little Rock, Arkansas, United States +11 more

Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

NCT ID: NCT06726330

The FIMBRIMENOP-2402 study is a clinical trial designed to explore ways to lower the risk of ovarian and pelvic cancer in women who have certain genetic mutations, such as BRCA1 or BRCA2. This stud...

Not yet recruiting

Phase: NA Type: interventional Locations: Bordeaux, , France, Nice, , France +21 more

A Biomarker Screening Protocol for Participants With Solid Tumors

NCT ID: NCT05891197

**Clinical Trial Summary: Biomarker Screening for Solid Tumors** This clinical trial is focused on a screening process that helps identify patients with specific types of solid tumors, such as adv...

Enrolling by invitation

Type: observational Locations: Rocky Mount, North Carolina, United States, Rocky Mount, North Carolina, United States

Surgery for Ovarian Cancer After PARPi Therapy in Precision

NCT ID: NCT06602063

This clinical trial is exploring a new treatment approach for women with certain types of ovarian cancer that have come back after initial treatment. Specifically, it looks at whether surgery to re...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China, Wuhan, , China

A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer

NCT ID: NCT05200364

This clinical trial is studying a new treatment called STRO-002, which is combined with another drug called Bevacizumab, to see how safe and effective it is for women with certain types of ovarian ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Milwaukee, Wisconsin, United States +5 more

Diet, Hepcidin, and Chemotherapy RDI

NCT ID: NCT06483997

This clinical trial is looking at how what women eat before starting chemotherapy for certain types of cancer affects a substance in the body called hepcidin, which can influence how well chemother...

Recruiting

Type: observational Locations: Washington, District Of Columbia, United States

Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers

NCT ID: NCT06492070

This clinical trial is studying two different ways to help prevent a common side effect of a chemotherapy drug called paclitaxel, which is often used to treat gynecological cancers like ovarian or ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States +1 more

RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression

NCT ID: NCT06420973

This clinical trial is exploring a new treatment for women with certain types of ovarian cancer, specifically those whose cancer has returned after initial treatment and who have a specific protein...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

NCT ID: NCT06161272

This clinical trial is studying a new treatment approach for women with certain types of ovarian cancer that has returned after being treated with other therapies. The researchers want to find out ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Nanning, Guangxi, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions